Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor

BACKGROUND: Type 2 diabetes mellitus has become one of the most important public health concerns worldwide. Due to its high prevalence and morbidity, there is an avid necessity to find new therapies that slow the progression and promote the regression of the disease. Imatinib mesylate is a tyrosine...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Sámano, Miguel Ángel, Baquerizo-Burgos, Jorge Enrique, Coronel, Melissa Fabiola Coronel, Wong-Campoverde, Buileng Daniela, Villanueva-Martinez, Fernando, Molina-Botello, Diego, Avila-Rojo, Jose Alonso, Palacios-Báez, Lucía, Cuevas-Ramos, Daniel, Gomez-Perez, Francisco Javier, Zentella-Dehesa, Alejandro, Aguayo-González, Álvaro, Gulias-Herrero, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215634/
https://www.ncbi.nlm.nih.gov/pubmed/30390651
http://dx.doi.org/10.1186/s12902-018-0303-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215634/
https://www.ncbi.nlm.nih.gov/pubmed/30390651
http://dx.doi.org/10.1186/s12902-018-0303-x

Ejemplares similares